1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
International Research in Infectious Diseases (R01 Clinical Trial Not Allowed) is a grant from the National Institutes of Health (NIH) that funds high-priority infectious disease research by international investigators in resource-constrained countries. The program supports regionally relevant research addressing infectious diseases of significant public health importance in low- and middle-income countries.
Organizations in low- and lower-middle-income economies by World Bank classification are particularly encouraged. Awards range from $125,000 to $500,000. Eligible applicants are non-domestic organizations headquartered in resource-constrained countries as classified by the World Bank.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
International Research in Infectious Diseases (R01 Clinical Trial Not Allowed) | Research Funding National Institutes of Health International Research in Infectious Diseases (R01 Clinical Trial Not Allowed) The purpose of this Funding Opportunity Announcement (FOA) is to support applications for high-priority, regionally relevant infectious diseases research by international investigators in resource-constrained countries.
Applicant organizations must be headquartered in foreign (non-U.S.) resource-constrained countries (i.e. low-income economies, lower-middle-income economies, and upper-middle-income economies by World Bank Classification ). Applicant organizations headquartered in low- and lower-middle income economy countries are particularly encouraged to apply.
Eligibility status of applicant organizations will be determined by the World Bank Classification list at the time of application submission. Letter of Intent Due Date: 30 days prior to Application Due Date.
Application Due Dates: August 2, 2023; August 2, 2024; AIDS Application Due Dates: August 2, 2023; August 2, 2024; RFA-AI-23-023 Expiration Date: New Date May 24, 2025 per NOT-OD-25-113 (Originally August 02, 2025 ) Applicant organizations must be headquartered in foreign (non-U.S.) resource-constrained (i.e. low-income economies, lower-middle-income economies, and upper-middle-income economies) by World Bank Classification at the time of application submission.
Applicant organizations headquartered in low- and lower-middle income economy countries are particularly encouraged to apply. PDs/PIs must have a primary appointment at an institution/organization in an eligible country. Investigators who currently serve or have served as PDs/PIs on R01-equivalent grants (other than an expiring/current IRID) or contracts funded by NIH are not eligible to apply.
For institutions/organizations proposing multiple PDs/PIs, all PDs/PIs must have primary appointment at an institution/organization in an eligible country. Application budgets should not exceed $125,000 in direct costs per year, and should reflect the actual needs of the project. The scope of the proposed project should determine the project period.
The maximum project period is 5 years. International Opportunities Medical - Clinical Science
According to the current listing, eligibility includes: Non-domestic entities (foreign organizations); non-domestic entities (foreign institutions); and others. Confirm the full requirements in the official notice before applying.
The current listing shows $125,000 - $500,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
International Research in Infectious Diseases (R01 Clinical Trial Not Allowed) is funded by National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article